Description
The pharmaceutical (pharma) industry is undergoing dramatic changes in its operating environment due to globalisation, heightened transparency expectations and an increased exposure to innovative technologies. Challenges impacting the traditional business model include escalating cost and pricing pressures, increasing competition,shorter time in market, expiring patents, declining profitability and mountingregulatory scrutiny. These challenges are compounded by the social and economic pressures facing the wider health ecosystem.
